Porosome Therapeutics Announces Groundbreaking Approach to Advance Diabetes Treatment
BOSTON--(BUSINESS WIRE)--Oct 30, 2023--Porosome Therapeutics, Inc. (Porosome Therapeutics) has announced a new and distinctive therapy for Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D) targeting the insulin secretory defects founds in beta cells associated with the disease. Porosome ...

